← Back to Clinical Trials
Recruiting NCT07143825

NCT07143825 A National Multicenter Survey on Small Vulnerable Newborns

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07143825
Status Recruiting
Phase —
Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Condition Preterm
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-04-01
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2025-04-01 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this nationwide multicenter observational study is to comprehensively investigate the severity of Small Vulnerable Newborns (SVN) issues across China and to propose further preventive and intervention measures. The primary aim is to provide a thorough description of SVN problems using a unified definition and framework, and to develop targeted prevention strategies. Participating centers across the country will collect clinical data on vulnerable newborns under their care and complete detailed questionnaires to support this research.

Eligibility Criteria

Inclusion Criteria: 1. Newborns diagnosed as vulnerable infants at the participating hospitals between January 1 and December 31, 2024; 2. Meeting any one of the following criteria: * Diagnosed as small for gestational age (SGA): birth weight below the 10th percentile for infants of the same gestational age and sex; * Preterm infants: gestational age less than 37 weeks; * Low Birth Weight (LBW) infants: birth weight less than 2,500 grams. Exclusion Criteria: * Incomplete medical records due to missing data preventing comprehensive case evaluation.

Contact & Investigator

Central Contact

Yongjun Zhang

✉ zhangyongjun@sjtu.edu.cn

📞 +86-13651736760

Frequently Asked Questions

Who can join the NCT07143825 clinical trial?

This trial is open to participants of all sexes, studying Preterm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07143825 currently recruiting?

Yes, NCT07143825 is actively recruiting participants. Contact the research team at zhangyongjun@sjtu.edu.cn for enrollment information.

Where is the NCT07143825 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT07143825 clinical trial?

NCT07143825 is sponsored by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology